Safety and Clinical Effect of Subcutaneous Human Interleukin-21 in Patients with Metastatic Melanoma or Renal Cell Carcinoma: A Phase I Trial (Q56838211)
Jump to navigation
Jump to search
scientific article published on 19 October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Clinical Effect of Subcutaneous Human Interleukin-21 in Patients with Metastatic Melanoma or Renal Cell Carcinoma: A Phase I Trial |
scientific article published on 19 October 2010 |
Statements
Safety and clinical effect of subcutaneous human interleukin-21 in patients with metastatic melanoma or renal cell carcinoma: a phase I trial (English)
Henrik Schmidt
Janet Brown
Ulrik Mouritzen
Peter Selby
Kirsten Fode
David Hal Mollerup
Poul F Geertsen
19 October 2010